18 October 2018
03 October 2018
Today patients and health budgets may sometimes be paying through the roof for expensive medicinal treatments that are not necessarily efficient. The position adopted today by the European Parliament, to pool efforts by Member States in testing how efficient medicines are, could change that.
14 September 2018
Many people struggle to get the medicines they need. This is a sad reality few would expect to happen in the EU. Yet, high costs and drug shortages do affect European patients – and are a huge strain on people’s private and the public purse. What is more, an increasing number of new medicines, sold at high prices, do not offer sufficient benefits compared to those which already exist on the market.
Our work areas
As consumers are faced with a growing amount of information from different sources, we advocate for high quality and non-promotional information about health products.
The ageing of the population, rising healthcare costs and the economic crisis are challenging the sustainability of healthcare systems and consumers’ access to treatments.
Health scandals such as the weight-loss drug Mediator and the faulty PIP breast implants keep undermining consumers’ confidence in the safety of available health products and their oversight by the competent authorities.
- Ensure consumers have access to high quality healthcare in all EU Member States
- Guarantee consumers benefit from safe and innovative treatments
- Allow consumers to make informed choices regarding their health